Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients

Gut
Ka Shing CheungWai K Leung

Abstract

Postcolonoscopy colorectal cancer (PCCRC) accounts for up to 9% of all CRCs. Statins have been shown to be associated with a lower CRC risk. We aimed to investigate whether PCCRC risk was also lower among statin users. This is a retrospective cohort study using a territory-wide electronic healthcare database in Hong Kong including patients aged 40 years or above who had undergone colonoscopies between 2005 and 2013. Exclusion criteria included prior colorectal cancer (CRC), inflammatory bowel disease, prior colectomy and CRC detected within 6 months of index colonoscopy. We defined statin use as at least 90-day use before index colonoscopy. Medication use was traced up to 5 years before index colonoscopy. PCCRC-3y was defined as cancer diagnosed between 6 and 36 months after index colonoscopy. Sites of CRC were categorised as proximal (proximal to splenic flexure) and distal cancer. The subdistribution HR (SHR) of PCCRC-3y with statin use was derived by propensity score matching based on covariates (including patient factors, concurrent medication use and endoscopy centre's performance). Of 187 897 eligible subjects, 854 (0.45%) were diagnosed with PCCRC-3y. Statin use was associated with a lower PCCRC-3y risk (SHR: 0.72; 95% C...Continue Reading

References

Mar 1, 1995·Cancer Causes & Control : CCC·E Giovannucci
Dec 30, 1993·The New England Journal of Medicine·S J WinawerJ F Panish
May 14, 1998·International Journal of Cancer. Journal International Du Cancer·S FranceschiA Decarli
Jun 30, 2000·The New England Journal of Medicine·P A Jänne, R J Mayer
Jun 26, 2002·Neoplasia : an International Journal for Oncology Research·Jim DimitroulakosSuzanne Kamel-Reid
Oct 16, 2002·Annals of Internal Medicine·Leonard E Braitman, Paul R Rosenbaum
Apr 14, 2006·Basic & Clinical Pharmacology & Toxicology·Robert J GlynnTil Stürmer
Jan 5, 2007·Journal of the National Cancer Institute·Patricia F CooganLynn Rosenberg
Aug 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefanos BonovasNikolaos M Sitaras
Jan 4, 2008·International Journal of Cancer. Journal International Du Cancer·Hang XiaoChung S Yang
Dec 17, 2008·Annals of Internal Medicine·Nancy N BaxterLinda Rabeneck
Jun 16, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Steven J HeitmanBrenda R Hemmelgarn
Nov 12, 2009·The American Journal of Gastroenterology·Harminder SinghCharles N Bernstein
Dec 17, 2009·The American Journal of Gastroenterology·Mustafa A ArainAasma Shaukat
Sep 30, 2010·The American Journal of Gastroenterology·Harminder SinghCharles N Bernstein
Jan 5, 2011·Annals of Internal Medicine·Hermann BrennerMichael Hoffmeister
Sep 14, 2011·The American Journal of Gastroenterology·Hiroki YuharaPatricia A Buffler
Feb 24, 2012·The New England Journal of Medicine·Ann G ZauberJerome D Waye
Sep 18, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Paul Lochhead, Andrew T Chan
Sep 21, 2013·The New England Journal of Medicine·Reiko NishiharaAndrew T Chan
Nov 23, 2013·Cancer Causes & Control : CCC·Yanqiong LiuXue Qin
Mar 4, 2014·World Journal of Gastroenterology : WJG·Theodore LytrasStefanos Bonovas
Jun 4, 2014·Gastrointestinal Endoscopy·Nicholas G BurgessMichael J Bourke
Jun 25, 2014·The American Journal of Gastroenterology·Siddharth SinghN Jewel Samadder
Sep 7, 2014·Gut·S SanduleanuUNKNOWN Expert Working Group on ‘Right-sided lesions and interval cancers’, Colorectal Cancer Screening Committee, World Endoscopy O
Apr 5, 2016·Journal of Gastroenterology and Hepatology·Yoon Suk JungDong Soo Han
Mar 23, 2017·JAMA : the Journal of the American Medical Association·Wallis C Y LauIan C K Wong
Jan 3, 2018·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Catherine S JohnsonJason Wenderoth
Jan 24, 2018·Journal of the National Cancer Institute·Ka Shing CheungWai K Leung
Oct 18, 2018·Journal of the National Cancer Institute·Ka Shing CheungWai K Leung

❮ Previous
Next ❯

Citations

Sep 27, 2019·MMW Fortschritte der Medizin·G Klose
Jul 12, 2019·World Journal of Gastroenterology : WJG·Ka-Shing CheungWai-Kay Seto
Jan 21, 2021·Nature Reviews. Clinical Oncology·Jiajie HouBeicheng Sun
Mar 5, 2021·Clinics and Research in Hepatology and Gastroenterology·Liusheng LiWu Yu
Jun 23, 2021·European Heart Journal·Qing-Wen RenKai-Hang Yiu
Oct 13, 2021·Alimentary Pharmacology & Therapeutics·Fanny E R VuikManon C W Spaander
Nov 4, 2021·The American Journal of Gastroenterology·Yin ZhangEdward L Giovannucci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.